Description

Viropil Tablets contain a fixed-dose combination of Dolutegravir, Lamivudine, and Tenofovir, commonly prescribed as part of antiretroviral therapy. This medicine is intended for controlled, long-term treatment plans and must be taken exactly as directed by a qualified medical practitioner.

Manufactured under strict pharmaceutical standards, Viropil supports adherence to modern HIV care protocols. As a prescription-only medication, it requires medical evaluation, dosage planning, and continuous monitoring by a licensed healthcare provider to ensure safe and effective use.

Patients should never alter dosing or discontinue treatment without consulting their doctor. Proper storage and handling according to package instructions help maintain product integrity.

Important Note:
Viropil should not be used without medical supervision. Only a registered healthcare professional can determine suitability, dosage, and duration. Follow all regulatory and medical guidelines when purchasing or using prescription antiretroviral medicines.